MicroPort

MicroPort Scientific Corporation, originating from Shanghai MicroPort Medical (Group) Co., Ltd. founded in 1998, is a leading Chinese innovative high-end medical device group registered in the Cayman Islands. Headquartered in Zhangjiang Science City, Shanghai, China, its business spans ten major clusters: cardiovascular intervention and structural heart disease treatment, cardiac rhythm management and electrophysiology, orthopedic implants and repair, aortic and peripheral vascular intervention, neurointervention and brain science, diabetes and endocrine management, urology and gynecological diseases, surgical operations, medical robotics, and artificial intelligence. MicroPort has established key production (R&D) bases in Shanghai, Suzhou, Jiaxing, Dongguan in China, Memphis in the United States, near Paris in France, near Milan in Italy, and the Dominican Republic, forming a globalized R&D, manufacturing, marketing, and service network. MicroPort is committed to continuously innovating to provide doctors with optimal and accessible medical solutions that can save and reshape patients' lives or improve their quality of life.